ALTO-207 is a fixed-dose combination of pramipexole, a dopamine D3/D2 agonist with antidepressant activity demonstrated across multiple prior studies, and ondansetron, a 5-HT3 antagonist anti-emetic.

Data provides us with a vast amount of information about almost any subject. But it is also easy to be fooled by a partial presentation of data. Some entrepreneurs will tell you that revenue is all ...